Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Immunology
Reference63 articles.
1. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer;Baselga;J. Clin. Oncol.,1996
2. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer;Baselga;Semin. Oncol.,1999
3. What can we learn from Herceptin trials in metastatic breast cancer?;Bell;Oncology,2002
4. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer;Broeckel;J. Clin. Oncol.,1998
5. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial;Burns;Bone Marrow Transplant.,2003
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy;Translational Oncology;2024-02
2. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer;Life Sciences;2023-10
3. Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers;Frontiers in Endocrinology;2023-04-27
4. Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends;International Journal of Molecular Sciences;2023-04-16
5. In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy;Frontiers in Immunology;2023-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3